Blue Trust Inc. Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Blue Trust Inc. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,467 shares of the medical equipment provider’s stock after acquiring an additional 734 shares during the period. Blue Trust Inc.’s holdings in Intuitive Surgical were worth $2,332,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical in the third quarter worth $558,807,000. International Assets Investment Management LLC grew its position in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares during the period. FMR LLC lifted its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB boosted its stake in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, Strategic Financial Concepts LLC grew its holdings in Intuitive Surgical by 50,740.8% in the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after purchasing an additional 312,056 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $595.55 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. The stock’s 50-day simple moving average is $559.48 and its two-hundred day simple moving average is $519.06.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Truist Financial upped their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.